Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles

David B. Seifer, David T. MacLaughlin, Benjamin P. Christian, Bo Feng, Robert M. Shelden

Research output: Contribution to journalArticle

388 Scopus citations


Objective: To test the hypothesis that the concentration of early follicular phase serum müllerian-inhibiting substance (MIS) is associated with ovarian response in women undergoing ovulation induction in preparation for assisted reproductive technology (ART). Design: Retrospective analysis of frozen day 3 serum samples. Setting: Academic ART program. Patient(s): One sample of frozen day 3 serum from women with ≤6 retrieved oocytes (n = 28) compared with women with ≥11 oocytes retrieved (n = 79) in preparation for IVF.Intervention(s): None. Main Outcome Measure(s): Comparison of day 3 serum MIS levels between two groups of women. Other comparisons included maximum serum E2 concentrations, number of retrieved oocytes, and percentage of mature oocytes between groups. Result(s): Mean serum MIS concentrations were 1.0 ± 0.4 ng/mL compared with 2.5 ± 0.3 ng/mL, or more than a 2.5-fold greater serum concentration of MIS in the group with ≥11 oocytes retrieved compared with in the group with ≤6 retrieved oocytes. Conclusion(s): These data demonstrate an association between early follicular phase serum MIS and the number of retrieved oocytes. Higher day 3 serum MIS concentrations were associated with greater number of retrieved oocytes.

Original languageEnglish (US)
Pages (from-to)468-471
Number of pages4
JournalFertility and sterility
Issue number3
StatePublished - Mar 9 2002



  • ART
  • Ovarian response
  • Serum MIS

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this